Vaduz Liechtenstein Charlevoix Sovereign Strategic Investment Fund
Additional shared vehicles: SV Biotech Crossover Opportunities Fund, L.P. (2025 Vintage) · Sapphire Emerging Ventures VII (2025 Vintage)
$4.8B Total AUM · Institutional LP profile covering 20 historical fund disclosure records ($521.1M parsed USD across disclosed rows) across disclosed strategy exposure in Buyout, Secondaries, Private Credit, Venture Capital, Infrastructure (investment geography mandates are evaluated separately from LP headquarters). 5 complete primary source trails are open below without registration.
Showing 5 open preview records out of 20 total tracked records (+15 gated pilot rows). Click Inspect Source on any row to view field-level substantiation, table headers/units, and archived page excerpts without login.
| Disclosed Fund / Vehicle | Strategy | Fund Vintage | Disclosed Amount | Disclosed Performance | Primary Source Trail |
|---|---|---|---|---|---|
| Coller International Partners IX, L.P. | Secondaries | 2025 |
$46.1M
General webpage link · Exact filing & amount pending · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · Allocator Webpage (Unanchored URL) |
| American Securities Partners IX, L.P. | Buyout | 2025 |
$43.8M
General webpage link · Exact filing & amount pending · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · Allocator Webpage (Unanchored URL) |
| Oak Hill Advisors Strategic Credit Fund IV, L.P. | Private Credit | 2025 |
$43.8M
General webpage link · Exact filing & amount pending · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · Allocator Webpage (Unanchored URL) |
| SV Life Sciences Fund VI, L.P. | Buyout | 2025 |
$43.8M
General webpage link · Exact filing & amount pending · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · Allocator Webpage (Unanchored URL) |
| SV Biotech Crossover Opportunities Fund, L.P. | Buyout | 2025 |
$33.2M
General webpage link · Exact filing & amount pending · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · Allocator Webpage (Unanchored URL) |
Tracked separately from historical commitments: active RFPs/searches, board pacing plans, leadership/CIO updates, and retained gatekeeper consultants.
Al Rashed Group Investment Office (Family Office / MFO, $4.8B AUM): Disclosed FY2025-2026 Private Markets Pacing & Allocation Update (PE Target 30.0% vs. 28.4% Actual; $76.8M Unallocated Target Bandwidth). FY2026 Gulf / MENA global buyout, technology/AI venture, healthcare & infrastructure GP fund and co-investment pacing (Al Khobar / Riyadh, Saudi Arabia). Gatekeeper / Intake Conduit: Mercer.
Forward-looking board pacing or target-allocation policy update · Recorded 2025-05-08
Board-Approved Pacing Plans, Active RFPs & Target-vs-Actual Allocation Gap
Join waitlist for pacing dossier →
Retained Private Markets Advisors & Emerging-Manager Search Conduits
Join waitlist for consultant map →
CIO, Private Markets Officers & Official Pitch Intake Guidance
Join waitlist for team directory →
You are viewing 5 open public preview records (out of 20 total tracked records for Al Rashed Group Investment Office) with zero-registration primary source trails. Join the early-access waitlist to request pilot access:
Enter your firm email to request pilot onboarding for Al Rashed Group Investment Office and our interactive GP workspace.
Thank you for joining the Prilago early-access waitlist! We will reach out with pilot access details for your firm.
Al Rashed Group Investment Office is categorized under Family Office / MFO (Regional Roadshow Hub: Middle East; Headquarters: Al Khobar / Riyadh, Saudi Arabia). Across 20 historical disclosure records tracked on Prilago ($521.1M total parsed USD across disclosed rows), the median disclosed amount is $21.2M (range: $5.0M to $53.0M).
Al Rashed Group Investment Office has disclosed records across Buyout, Secondaries, Private Credit, Venture Capital, Infrastructure. Open preview records include Coller International Partners IX, L.P. (2025 Vintage), American Securities Partners IX, L.P. (2025 Vintage), Oak Hill Advisors Strategic Credit Fund IV, L.P. (2025 Vintage), SV Life Sciences Fund VI, L.P. (2025 Vintage).
Records for Al Rashed Group Investment Office cite primary public disclosures (Allocator Webpage (Unanchored URL)), and visitors can inspect 5 open source trails on this profile without registration. Each source trail displays field-level substantiation status, distinguishing exact commitment schedules from carrying-value or fee tables. Forward-looking active searches, RFPs, pacing plans, and governance updates are separated from historical disclosures.
General Partners can join the early-access waitlist on https://prilago.com/lp/al-rashed-group-investment-office or test fund suitability in the interactive read-only demo at https://prilago.com/demo.
In Prilago's bilateral commitment graph, Al Rashed Group Investment Office shares resolved underlying fund vehicles with 666 institutional LPs across 20 shared vehicles (shared fund exposure represents a potential introduction path and does not prove LPAC seat overlap or personal acquaintance). Top shared-fund peers include Vaduz Liechtenstein Charlevoix Sovereign Strategic Investment Fund (8 shared vehicles, e.g. SV Life Sciences Fund VI, L.P. (2025 Vintage)), Delmarva Fauquier Livingston Multi-Family Office Private Capital Platform (8 shared vehicles, e.g. SV Biotech Crossover Opportunities Fund, L.P. (2025 Vintage)), Fairfield County Hopewell Pendleton Institutional Outsourced CIO & Wealth Advisory (8 shared vehicles, e.g. Sapphire Emerging Ventures VII (2025 Vintage)).